BACKGROUND: The decision to pursue fertility preservation (FP) after a cancer diagnosis is complex. We examined the prevalence of high decisional conflict and specific factors that influence this decision using the Decisional Conflict Scale (DCS). METHODS: The FIRST project is a web-based survey of female cancer survivors (ages 18-44 years) who have undergone gonadotoxic treatment. We evaluated the association between recalled decisional conflict and referral to FP counseling and demographic, socioeconomic, and cancer variables. RESULTS: Of 208 participants, 115 subjects (55%) had scores consistent with high decisional conflict (DCS score >37.5 of 100), and 43 (21%) were in the moderate range (25-37.5). In unadjusted analysis, high decisional conflict was associated with lack of referral to FP consultation, not undergoing FP treatment, concerns regarding FP cost, length of survivorship, lower income, education, partner status, and cancer type. In multivariable analysis, significantly higher prevalence of high decisional conflict was observed in participants who were not referred for FP consultation (prevalence ratio [PR], 1.25; 95% confidence interval [CI], 1.06-1.47), as well as in participants who reported cost of FP services to be prohibitive (PR, 1.16 [95% CI, 1.03-1.31]). Prevalence of high DCS was lower for women who underwent FP treatment (PR, 0.67 [95% CI, 0.52-0.86]). CONCLUSIONS: In this study of female young adult cancer survivors, the majority recalled significant decisional conflict about FP at cancer diagnosis. Increasing access to FP via referral for counseling and cost reduction may decrease decisional conflict about FP for young patients struggling with cancer and fertility decisions.
BACKGROUND: The decision to pursue fertility preservation (FP) after a cancer diagnosis is complex. We examined the prevalence of high decisional conflict and specific factors that influence this decision using the Decisional Conflict Scale (DCS). METHODS: The FIRST project is a web-based survey of female cancer survivors (ages 18-44 years) who have undergone gonadotoxic treatment. We evaluated the association between recalled decisional conflict and referral to FP counseling and demographic, socioeconomic, and cancer variables. RESULTS: Of 208 participants, 115 subjects (55%) had scores consistent with high decisional conflict (DCS score >37.5 of 100), and 43 (21%) were in the moderate range (25-37.5). In unadjusted analysis, high decisional conflict was associated with lack of referral to FP consultation, not undergoing FP treatment, concerns regarding FP cost, length of survivorship, lower income, education, partner status, and cancer type. In multivariable analysis, significantly higher prevalence of high decisional conflict was observed in participants who were not referred for FP consultation (prevalence ratio [PR], 1.25; 95% confidence interval [CI], 1.06-1.47), as well as in participants who reported cost of FP services to be prohibitive (PR, 1.16 [95% CI, 1.03-1.31]). Prevalence of high DCS was lower for women who underwent FP treatment (PR, 0.67 [95% CI, 0.52-0.86]). CONCLUSIONS: In this study of female young adult cancer survivors, the majority recalled significant decisional conflict about FP at cancer diagnosis. Increasing access to FP via referral for counseling and cost reduction may decrease decisional conflict about FP for young patients struggling with cancer and fertility decisions.
Authors: A M O'Connor; D Stacey; D Rovner; M Holmes-Rovner; J Tetroe; H Llewellyn-Thomas; V Entwistle; A Rostom; V Fiset; M Barry; J Jones Journal: Cochrane Database Syst Rev Date: 2001
Authors: K A Metcalfe; A Poll; A O'Connor; S Gershman; S Armel; A Finch; R Demsky; B Rosen; S A Narod Journal: Clin Genet Date: 2007-09 Impact factor: 4.438
Authors: Stephanie J Lee; Leslie R Schover; Ann H Partridge; Pasquale Patrizio; W Hamish Wallace; Karen Hagerty; Lindsay N Beck; Lawrence V Brennan; Kutluk Oktay Journal: J Clin Oncol Date: 2006-05-01 Impact factor: 44.544
Authors: Samantha C Roberts; Amber Knight; Brian W Whitcomb; Jessica R Gorman; Andrew C Dietz; H Irene Su Journal: J Cancer Surviv Date: 2017-03-06 Impact factor: 4.442
Authors: Sally A Dominick; Brian W Whitcomb; Jessica R Gorman; Jennifer E Mersereau; Karine Chung; H Irene Su Journal: J Cancer Surviv Date: 2014-05-24 Impact factor: 4.442
Authors: Ksenya Shliakhtsitsava; Sally A D Romero; Brian W Whitcomb; Jessica R Gorman; Samantha Roberts; H Irene Su Journal: J Adolesc Young Adult Oncol Date: 2017-07-21 Impact factor: 2.223
Authors: Alexandra Higgins; Zaraq Khan; Charles C Coddington; Shahrukh K Hashmi; Mehrdad Hefazi; Hassan Alkhateeb; Mark R Litzow; William J Hogan; Elizabeth Cathcart-Rake; Carrie A Thompson; Mrinal M Patnaik Journal: Biol Blood Marrow Transplant Date: 2019-02-15 Impact factor: 5.742
Authors: Katie Young; Ksenya Shliakhtsitsava; Loki Natarajan; Emily Myers; Andrew C Dietz; Jessica R Gorman; María Elena Martínez; Brian W Whitcomb; H Irene Su Journal: Cancer Date: 2018-11-29 Impact factor: 6.860
Authors: R Anguzu; R Cusatis; N Fergestrom; A Cooper; K D Schoyer; J B Davis; J Sandlow; K E Flynn Journal: Hum Reprod Date: 2020-03-27 Impact factor: 6.918